More articles from Supplement

Despite the odds, the transplant field has progressed rapidly
John J. Fung, MD, PhD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S25-S26;
A regulatory and legal perspective: Issues in off-label device use
Rebecca Dresser, JD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S63-S64;
A continued need for evidence-based guidance
James B. Young, MD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S26-S28;
A historical perspective: The more things change, the more they remain the same
Paul A. Lombardo, PhD, JD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S65-S66;
What does—and does not—spur innovation?
Thomas E. Starzl, MD, PhD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S28-S29;
An economic value perspective: Setting limits on health care can be ethical
Peter A. Ubel, MD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S67-S69;
Panel discussion
Mark Siegler, MD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S30-S32;
An industry perspective: Proactive self-regulation through an industry code of ethics
Christopher L. White, Esq
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S69-S70;
Medical professionalism in a commercialized health care market
Arnold S. Relman, MD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S33-S36;
Panel discussion
Lawrence K. Altman, MD
Cleveland Clinic Journal of Medicine November 2008, 75 (11 suppl 6) S70-S73;

Pages